Astrazeneca Presents New Data Demonstrating CrestorŽ Reduced C-Reactive Protein Levels In African-American Patients
CRESTOR reduced CRP in African-American patients by up to 21 percent - New ARIES (African American Rosuvastatin Investigation of Efficacy and Safety) data presented today at the American College of Cardiology's Annual Meeting (ACC) show that AstraZeneca's CRESTORŽ (rosuvastatin calcium) at 10 and 20 mg reduced levels of C-Reactive Protein (...
Continue to Astrazeneca Presents New Data Demonstrating CrestorŽ Reduced C-Reactive Protein Levels In African-American Patients on Medical News Today.
Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz